142 related articles for article (PubMed ID: 3888679)
1. Altered androstenedione and estrone dynamics associated with abnormal hormonal profiles in amenorrheic subjects with weight loss or obesity.
Loughlin T; Cunningham SK; Culliton M; Smyth PP; Meagher DJ; McKenna TJ
Fertil Steril; 1985 May; 43(5):720-5. PubMed ID: 3888679
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
3. Variable clinical and hormonal manifestations of hyperandrogenemia.
McKenna TJ; Loughlin T; Daly L; Smyth PA; Culliton M; Cunningham SK
Metabolism; 1984 Aug; 33(8):714-7. PubMed ID: 6748943
[TBL] [Abstract][Full Text] [Related]
4. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
6. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
7. The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.
Wajchenberg BL; Achando SS; Mathor MM; Czeresnia CE; Giannella Neto D; Kirschner MA
Fertil Steril; 1988 Jan; 49(1):56-61. PubMed ID: 3121397
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
9. Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome.
Byrne B; Cunningham S; Igoe D; Conroy R; McKenna TJ
Acta Endocrinol (Copenh); 1991 Apr; 124(4):370-4. PubMed ID: 1827700
[TBL] [Abstract][Full Text] [Related]
10. Endocrine profile in breast cancer patients receiving chemotherapy.
Mehta RR; Beattie CW; Das Gupta TK
Breast Cancer Res Treat; 1992 Jan; 20(2):125-32. PubMed ID: 1554888
[TBL] [Abstract][Full Text] [Related]
11. Plasma hormone profile in anovulation.
Wu CH; Mikhail G
Fertil Steril; 1979 Mar; 31(3):258-66. PubMed ID: 571358
[TBL] [Abstract][Full Text] [Related]
12. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.
Lobo RA; Granger L; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1981 Jan; 52(1):156-8. PubMed ID: 6778890
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
14. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.
DeVane GW; Czekala NM; Judd HL; Yen SS
Am J Obstet Gynecol; 1975 Feb; 121(4):496-500. PubMed ID: 125040
[TBL] [Abstract][Full Text] [Related]
15. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
Dunaif A; Graf M
J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
Siegberg R; Nilsson CG; Stenman UH; Widholm O
Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
[TBL] [Abstract][Full Text] [Related]
17. Profiles and endocrine correlations in endometrial carcinoma.
Falsetti L; Omodei U; Dordoni D; Scagliola P; Turla R; Zotti L; Archetti L
Eur J Gynaecol Oncol; 1983; 4(1):30-4. PubMed ID: 6407836
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
19. Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease.
Laatikainen T; Tulenheimo A; Andersson B; Kärkkäinen J
Eur J Obstet Gynecol Reprod Biol; 1983 Apr; 15(1):45-53. PubMed ID: 6224711
[TBL] [Abstract][Full Text] [Related]
20. Hormonal characteristics of women with clinical features of the polycystic ovary syndrome.
Heineman MJ; Thomas CM; Doesburg WH; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):263-71. PubMed ID: 6430730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
